How do prescribers see restricted antimicrobial criteria?

Publish your restricted-antimicrobial criteria and approval contacts in your stewardship space. Prescribers can open them in the mobile app, on the web or through an EHR link, and ask questions with citations to the source.

How does the IDSA comparison scan work?

The scan compares your local guidance against IDSA and other national guidelines, flagging differences in first-line agent, dose, duration and references. Your committee reviews the differences and decides what is appropriate for your local resistance patterns and formulary.

How do updates stay in sync with national guidance?

When national guidance changes, Eolas identifies affected local guidelines and drafts proposed edits for your team. Nothing is published until a named approver signs it off.

Who approves changes and is there an audit trail?

Your team assigns named editors and approvers. Version history and a full audit trail record each edit and approval, with automatic review dates and role-based access.

Does Ask Eolas answer from the internet?

No. Ask Eolas answers only from your approved guidance, with citations. Answers reflect your local documents, not an internet search.

Do you store patient data?

No. Eolas stores your institutional guidance, not patient data.

What evidence is there?

A randomized simulation study published in npj Antimicrobials and Resistance in 2026 found 100% prescribing accuracy with Ask Eolas versus 47% with PDF guidelines. Carilion Clinic reported stewardship resource access rising from 102 to 488 monthly views in an Open Forum Infectious Diseases 2026 abstract. Simulation findings and real-world resource use are distinct outcomes.

Can we migrate from MicroGuide or our intranet?

Yes. Bring your existing PDFs, Word documents and intranet pages into an ID and stewardship space, or migrate from MicroGuide. Your team retains control of organization, review and approval.

Infectious diseases and antimicrobial stewardship

5x the use of your antimicrobial guidelines.

Fewer unnecessary ID referrals. Less broad-spectrum prescribing. Fewer prescribing errors. Eolas puts your own stewardship guidance at every prescriber's fingertips, answers questions from it with citations, and keeps it aligned with IDSA.

Benchmark your guidelines against IDSA

Ask EolasID & stewardship

Where can I find our restricted antimicrobial criteria?

From your approved guidance

Your hospital's antimicrobial guideline contains the restricted-agent criteria and the local approval pathway. Review the source before prescribing.

Hospital antimicrobial guideline

Citation 1 · Restricted antimicrobials and approvals

Illustrative product view · example data

4.8x stewardship resource use: Carilion Clinic, OFID 2026
100% vs 47% prescribing accuracy: npj Antimicrobials and Resistance 2026
NNT 1.9: vs PDF guidelines

5x guideline use

Clinicians stop guessing and start opening your guidance. Carilion Clinic went from 102 to 488 stewardship resource views a month.

Fewer unnecessary referrals

Routine questions get answered from your guidance before they become a page to ID, micro or the stewardship pharmacist.

Less broad-spectrum use

Local first-line choices are one tap away, so narrower agents get chosen first. Carilion reduced broad-spectrum prescribing in UTI and viral URTI.

Fewer prescribing errors

In a randomized simulation study, prescribers using Ask Eolas made zero errors, versus eight with PDF guidelines.

The problem

Your guidelines are good. They're just not where the decision happens.

Buried

Guidance lives in PDFs, intranets and behind firewalls, so prescribers default to habit or broad cover.

Overstretched

A small stewardship team fields the same questions all day, by pager and phone.

Drifting

National guidance updates and local documents quietly fall out of date, with no record of who changed what.

Peer-reviewed evidence · Nature Portfolio

Published in npj Antimicrobials and Resistance

A randomized user-testing and simulation study with 45 clinicians (consultants, pharmacists, residents and prescribing nurses) compared Ask Eolas, the Eolas app and standard PDF guidelines on antimicrobial prescribing cases.

Prescribing accuracy in simulated cases

Ask Eolas100% (15/15)

Eolas app60% (9/15)

PDF guidelines47% (7/15)

0 prescribing errors: with Ask Eolas, vs 8 with PDF guidelines
53 point absolute improvement: in prescribing accuracy
NNT 1.9: vs PDF guidelines

Waldock WJ, Gilchrist M, Ashrafian H, Darzi A, ... Franklin BD. npj Antimicrob Resist 4, 16 (2026). Simulated evaluation; real-world trials are under way.

Read the paper

Real-world evidence

Carilion Clinic: from buried PDFs to the bedside

Six hospitals and roughly 280 outpatient practices in Virginia. ID, pharmacy and infection prevention launched an Eolas stewardship app in January 2025.

102 a month (2024) to 488 a month (2025): stewardship resource access, same four-month period, p = 0.005

2024 · Before Eolas102 / month

2025 · With Eolas488 / month

244 clinicians onboarded in 4 months
68% physicians and APPs, 27% pharmacists
Top users: emergency medicine 24%, family medicine 22%, surgery 16%, internal medicine 16%

Broad-spectrum use in UTI: [TBC]

Outcome figure awaiting confirmation.

Broad-spectrum use in viral URTI: [TBC]

Outcome figure awaiting confirmation.

Swann M, McDaniel L, Nowak E, Stornelli N, Baffoe-Bonnie A. Open Forum Infect Dis 13(Suppl 1), 2026 (IDWeek abstract 685).

Read the case study →Read the abstract →

How it works

Your stewardship guidance, at every prescribing decision

01
Bring your guidance in
Upload PDFs, Word docs and intranet pages, or migrate from MicroGuide. Organized into an ID and stewardship space your team controls.
02
Publish to every prescriber
Mobile app, web and EHR link, with restricted-antimicrobial criteria, dosing, IV-to-oral switch and micro guides in one place. Targeted notifications when something changes.
03
Answer at the point of care
Ask Eolas gives cited answers drawn only from your approved guidance, so the answer matches your antibiogram and formulary, not the internet.
04
See what prescribers need
Analytics on searches, views and unanswered questions show where guidance is missing or unclear, so you fix the gap instead of answering the same page again.

Ask Eolas: cited answers from your own guidance

Targeted notifications when your guidance changes

Guideline benchmarking

See exactly where your guidelines differ from IDSA

Run a scan that compares your local antimicrobial guidance against IDSA and other national guidelines. Eolas flags differences in first-line agent, dose, duration and outdated references, so your committee reviews the gaps that matter, with local resistance patterns still in your control.

Guideline comparison

Illustrative product view · example data

38 guidelines scanned · 6 differences flagged · 2 outdated references

Community-acquired pneumonia
Duration differs from national recommendation
Review
Uncomplicated cystitis
Reference cites superseded edition
Update
Cellulitis
Aligned
No action

Always current, fully audited

Stays current when national guidance changes

When IDSA or other national bodies publish an update, Eolas identifies which of your local guidelines are affected and drafts the proposed change for your team. Nothing goes live until a named approver signs it off.

1National update published
2Affected local guidelines flagged
3Suggested edits drafted
4Reviewed and approved by named owner
5Published to every prescriber, with notification

Version history
Full audit trail of every edit and approval
Automatic review dates
Named editors and approvers
SSO and role-based access
No patient data stored

Evidence for Joint Commission MM.09.01.01 and CMS stewardship Conditions of Participation, ready when surveyors ask.

Who it's for

Built for your stewardship team and the prescribers you support

ID physicians

Your local recommendations, available before a routine question becomes a referral.

Stewardship pharmacists

Restricted agent criteria, IV-to-oral guidance and prescribing questions in one governed space.

Microbiology and infection prevention

Micro guides and prevention policies that reach the teams who need them.

Front-line prescribers

ED, hospitalists, family medicine and surgery: your approved guidance at the point of care.

Evidence partner program

Help us measure impact on broad-spectrum use, referrals and C. difficile.

Partner sites get preferential terms.

Infection prevention teams use Eolas too

CLABSI
CAUTI
SSI
C. difficile
MRSA
Sepsis
MDROs

Quality and compliance

FAQ

Common questions

How do prescribers see restricted antimicrobial criteria?: Publish your restricted-antimicrobial criteria and approval contacts in your stewardship space. Prescribers can open them in the mobile app, on the web or through an EHR link, and ask questions with citations to the source.
How does the IDSA comparison scan work?: The scan compares your local guidance against IDSA and other national guidelines, flagging differences in first-line agent, dose, duration and references. Your committee reviews the differences and decides what is appropriate for your local resistance patterns and formulary.
How do updates stay in sync with national guidance?: When national guidance changes, Eolas identifies affected local guidelines and drafts proposed edits for your team. Nothing is published until a named approver signs it off.
Who approves changes and is there an audit trail?: Your team assigns named editors and approvers. Version history and a full audit trail record each edit and approval, with automatic review dates and role-based access.
Does Ask Eolas answer from the internet?: No. Ask Eolas answers only from your approved guidance, with citations. Answers reflect your local documents, not an internet search.
Do you store patient data?: No. Eolas stores your institutional guidance, not patient data.
What evidence is there?: A randomized simulation study published in npj Antimicrobials and Resistance in 2026 found 100% prescribing accuracy with Ask Eolas versus 47% with PDF guidelines. Carilion Clinic reported stewardship resource access rising from 102 to 488 monthly views in an Open Forum Infectious Diseases 2026 abstract. Simulation findings and real-world resource use are distinct outcomes.
Can we migrate from MicroGuide or our intranet?: Yes. Bring your existing PDFs, Word documents and intranet pages into an ID and stewardship space, or migrate from MicroGuide. Your team retains control of organization, review and approval.

The week in clinical evidence, in one email

New studies, guideline updates and journal summaries, pulled together for clinicians who do not have time to go looking.

See your own guidelines in Eolas.

Book a 30 minute demo and we'll load a sample of your stewardship guidance.